Uncategorized
What topics should SSDP leadership discuss? Vote today!
Each year, the Students for Sensible Drug Policy Strategy Summit convenes our board and staff, along with invited students and alumni, to review our progress over the last year, set our goals for the coming year, and engage in other high-level discussions related to the organization and our work. This year, as part of our ongoing efforts to engage our
The Festival of Freedom
Written by Yahav Erez ’17, founder of SSDP Israel A bit about today, April 19th, 76 years ago. Every year on this day, ‘Bicycle Day’ is celebrated in memory of the famous bike ride that the Swiss Chemist Albert Hofmann made from his laboratory to his nearby home on a spring evening. That ride, when he first started to notice
DAY TWO OF THE 62ND COMMISSION OF NARCOTIC DRUGS
SSDP staff and members are in Vienna this week with our youth allies in CSSDP, SSDP Australia, Youth Rise, and YODA attending the 62nd Commission on Narcotic Drugs meeting (“CND”). Yesterday, we shared an update from the first day of CND. Today, Ailish Brennan’18 of Youth RISE and University College Dublin SSDP shares her thoughts on the second day of
Day One Updates from the 62nd Commission on Narcotic Drugs
SSDP staff and members are in Vienna this week with our youth allies in CSSDP, SSDP Australia, Youth Rise, and YODA attending the 62nd Commission on Narcotic Drugs meeting (“CND”). Yesterday, we shared an update from last week’s High-Level Ministerial Segment. Today, SSDP’s International Program Manager, Jake Agliata ’11, summarizes the key events which took place during the first day
Psychedelics hasn’t escaped gender: If the rate of use is the same, how come we only hear from men?
This op-ed was written by Yahav Erez ’17, founder of SSDP Israel, and was originally published in Hebrew in Time Out Tel Aviv. Translation to English was provided by Miriam Erez. The nearly equal rates of use of psychedelics between men and women, as reported by Time Out Tel Aviv’s Big Drug Survey, should surprise us. Drugs are perceived of
Introducing the SSDP Black Caucus
I’m Logan Ward ’17, Students for Sensible Drug Policy’s HBCU Outreach Intern, and I’m organizing SSDP’s first Black Caucus as part of our antiracism initiative. Race caucusing provides a space to commune with, heal with, and create alongside other self-identified people of color. My model for a Black Caucus comes out of a desire to center Africana ways of knowing
Introducing our Rural Harm Reduction Policy Recommendations and Implementation Strategies
As a global network of students spanning vastly different communities and regions, it is important to give students the specific plans and tools necessary to create effective change in their neighborhoods. SSDP’s Rural Policy Working Group was created out of the desire of several students and SSDP alumni to collect and organize information to help activists in rural communities advocate
Board of Directors Applications Due This Weekend
Applications to run for student director seats on our Board of Directors are due this Sunday, February 17th, at 11:59pm PST. Now is your chance to play a critical role in the everyday functionality of SSDP – from fundraising to organizational goal setting and everything in between. Our student Congress which, among other things, elects student directors, will take place
SSDP2019 plenaries and early bird discount deadline
Last week, we told you about our amazing keynote speakers, Rick Doblin, Ph.D., Steven Hawkins, JD, and Antwan Jefferson, Ph.D., and today we’re excited to announce the plenary sessions at our biggest event of the year, SSDP2019: The Global Students for Sensible Drug Policy Conference: Beyond Drug Decriminalization: Local badasses transforming justice Highlighting local prison abolition and justice reform activists,
A Look Back at 2018 in Global Drug Policy
Written by Orsi Feher ’16, SSDP’s Europe Global Fellow The Commission on Narcotic Drugs (CND) is one of the three bodies assigned roles by the global drug control conventions, along with the International Narcotics Control Board (INCB), and the World Health Organization (WHO). CND is the central drug policy decision making body within the United Nations system and can vote
